In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1864 News Items found
Shanu Modi
In the Clinic
FDA Approves First Targeted Drug To Treat HER2-Low Breast Cancer: Trastuzumab Deruxtecan (T-DXd)

On August 5, 2022, the FDA approved the first targeted therapy for patients with HER2-low breast cancer that has spread to other parts of the body and is unable to be surgically removed. The drug, trastuzumab deruxtecan (T-DXd), was approved based on a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK) breast medical oncologist Shanu Modi.
MSK medical oncologist Smita Joshi, who specializes in esophageal cancer.
Q&A
Esophageal Cancer Risk: The Truth About Hot Drinks Like Coffee and Tea

There is very little evidence that drinking hot beverages increases esophageal cancer risk.
Man putting on sunscreen
Can Tattoos Hide Skin Cancer? Advice From MSK on How To Stay Safe

First, the good news: There’s no evidence that tattoos cause skin cancer, says Memorial Sloan Kettering Cancer Center (MSK) dermatologist Jennifer DeFa...
Memorial Sloan Kettering Cancer Center physician-scientist Richard Wong
Pancreatic Cancer Spreads With Help From Schwann Cells, MSK Researchers Find

Pancreatic cancer cells spread with the help of tracks laid by nerve-supporting cells called Schwann cells.
bowl of edamame
Does Eating Soy Increase Estrogen and Cause Breast Cancer?

Learn whether eating soy products causes cancer.
Medical oncologist Emily Feld
Q&A
Metastatic and Metastasized Cancers: Answers to 7 Common Questions

In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.
Hematologic oncologist Urvi Shah
Research Shows Plant-Based Diets Are Better Than Ketogenic Diets for Cancer Risk and Long-Term Health

Experts at Memorial Sloan Kettering Cancer Center reviewed the research and found that whole food plant based diets are better than ketogenic diets at reducing cancer risk and helping people after cancer treatment live healthier lives.
SKI molecular biologist John Maciejowski
SKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells

A protein in the body that protects against viruses can also cause cancer-related mutations.
Jason Mascolo with his wife, Tricia, and daughter, Maeve
In the Clinic
Molecular Testing Leads to Personalized Treatment for a Rare Sarcoma: Jason’s Story

Learn how molecular analysis of Jason’s sarcoma led to a personalized immunotherapy treatment that dramatically improved his prognosis. MSK is a leader in treating sarcoma.
Overcoming Stomach Cancer and the CDH1 Mutation, Thanks to MSK
Overcoming Stomach Cancer and the CDH1 Mutation, Thanks to MSK

Meghan Winston chose Memorial Sloan Kettering Cancer Center to surgically remove her stomach—called a total gastrectomy—to protect against a deadly form of stomach cancer caused by a rare mutation in the CDH1 gene.